Collapsing glomerulopathy: a review by the collapsing brazilian consortium

dc.creatorAlmeida, Jose Bruno de
dc.creatorCutrim, Érico Murilo Monteiro
dc.creatorNeves, Precil Diego Miranda de Meneses
dc.creatorCampos, Marcos Adriano Garcia
dc.creatorWanderley, Davi Campos
dc.creatorTeixeira Júnior, Antonio Augusto Lima
dc.creatorMuniz, Monique Pereira Rêgo
dc.creatorLadchumananandasivam, Francisco Rasiah
dc.creatorGomes, Orlando Vieira
dc.creatorVasco, Rafael Fernandes Vanderlei
dc.creatorBrito, Dyego José de Araújo
dc.creatorLages, Joyce Santos
dc.creatorSalgado-Filho, Natalino
dc.creatorGuedes, Felipe Leite
dc.creatorMagalhães, Marcelo
dc.creatorAraújo, Stanley de Almeida
dc.creatorSilva, Gyl Eanes Barros
dc.date2023-08-02T19:00:51Z
dc.date2023-08-02T19:00:51Z
dc.date2022
dc.date.accessioned2023-09-04T12:05:35Z
dc.date.available2023-09-04T12:05:35Z
dc.identifierALMEIDA, José Bruno, et. al. Collapsing Glomerulopathy: A Review by the Collapsing Brazilian Consortium. Frontiers In Medicine, v. 9, p. 846173, 2022.DOI: https://doi.org/10.3389/fmed.2022.846173 Disponível em: https://observatorio.fm.usp.br/handle/OPI/48634 Acesso em: 27 jul. 2023
dc.identifierhttps://repositorio.ufrn.br/handle/123456789/54341
dc.identifierhttps://doi.org/10.3389/fmed.2022.846173
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8599012
dc.descriptionCollapsing glomerulopathy (CG) is a clinicopathologic entity characterized by segmentar or global collapse of the glomerulus and hypertrophy and hyperplasia of podocytes. The Columbia classification of 2004 classified CG as a histological subtype of focal segmental glomerulosclerosis (FSGS). A growing number of studies have demonstrated a high prevalence of CG in many countries, especially among populations with a higher proportion of people with African descent. The present study is a narrative review of articles extracted from PubMed, Medline, and Scielo databases from September 1, 2020 to December 31, 2021. We have focused on populational studies (specially cross-sectional and cohort articles). CG is defined as a podocytopathy with a distinct pathogenesis characterized by strong podocyte proliferative activity. The most significant risk factors for CG include APOL1 gene mutations and infections with human immunodeficiency virus and severe acute respiratory syndrome coronavirus 2. CG typically presents with more severe symptoms and greater renal damage. The prognosis is notably worse than that of other FSGS subtypes
dc.formatapplication/pdf
dc.languageen
dc.publisherFrontiers in medicine
dc.rightshttps://creativecommons.org/licenses/by/4.0/
dc.rightsLOCKSS system has permission to collect, preserve, and serve this Archival Unit
dc.subjectcollapsing glomerulopathy
dc.subjectsegmental and focal glomerulosclerosis
dc.subjectnephrotic syndrome (NS)
dc.subjectrenal biopsy
dc.subjectpodocytes
dc.subjectglomerulopathy
dc.titleCollapsing glomerulopathy: a review by the collapsing brazilian consortium
dc.typearticle


Este ítem pertenece a la siguiente institución